[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG163564A1 - Kinin antagonists for treating bladder dysfunction - Google Patents

Kinin antagonists for treating bladder dysfunction

Info

Publication number
SG163564A1
SG163564A1 SG201004805-6A SG2010048056A SG163564A1 SG 163564 A1 SG163564 A1 SG 163564A1 SG 2010048056 A SG2010048056 A SG 2010048056A SG 163564 A1 SG163564 A1 SG 163564A1
Authority
SG
Singapore
Prior art keywords
bladder dysfunction
treating bladder
kinin antagonists
kinin
antagonists
Prior art date
Application number
SG201004805-6A
Other languages
English (en)
Inventor
Christoph Gibson
Gerd Hummel
Jochen Knolle
Ulrich Reineke
Thomas Tradler
Original Assignee
Jerini Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerini Ag filed Critical Jerini Ag
Publication of SG163564A1 publication Critical patent/SG163564A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG201004805-6A 2005-07-05 2006-07-04 Kinin antagonists for treating bladder dysfunction SG163564A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05014581A EP1741444A1 (de) 2005-07-05 2005-07-05 Antagonisten von Kinin zur Behandlung von Blasenfunktionsstoerungen

Publications (1)

Publication Number Publication Date
SG163564A1 true SG163564A1 (en) 2010-08-30

Family

ID=34937780

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201004805-6A SG163564A1 (en) 2005-07-05 2006-07-04 Kinin antagonists for treating bladder dysfunction

Country Status (17)

Country Link
US (1) US20080221039A1 (de)
EP (2) EP1741444A1 (de)
JP (1) JP2009500362A (de)
KR (1) KR20080025120A (de)
CN (1) CN101212985A (de)
AR (1) AR054820A1 (de)
AT (1) ATE521365T1 (de)
AU (1) AU2006265266A1 (de)
BR (1) BRPI0613724A2 (de)
CA (1) CA2613627A1 (de)
IL (1) IL188316A0 (de)
RU (1) RU2008104134A (de)
SG (1) SG163564A1 (de)
TW (1) TW200800249A (de)
UA (1) UA96573C2 (de)
WO (1) WO2007003411A2 (de)
ZA (1) ZA200711240B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
DE102005013967A1 (de) * 2004-11-05 2006-10-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
FR2919803B1 (fr) * 2007-08-07 2011-07-22 Sanofi Aventis Utilisation d'un antagoniste non peptidique du recepteur b1 pour la preparation de medicaments utiles pour le traitement de l'obesite et des pathologies liees a l'obesite ou au diabete
EP2240458B1 (de) * 2008-02-06 2011-08-03 Boehringer Ingelheim International GmbH Arylsulfonamide wirksam als schmerzmittel
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
US9415048B2 (en) 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20130323288A1 (en) 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
AU2012363788B2 (en) 2012-01-04 2017-03-09 Wellesley Pharmaceuticals, Llc Delayed-release formulation for reducing the frequency of urination and method of use thereof
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
CA2875818A1 (en) * 2012-07-27 2014-01-30 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
US10792326B2 (en) 2013-06-28 2020-10-06 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
WO2015017575A2 (en) 2013-08-01 2015-02-05 Dignify Therapeutics, Inc. Compositions and methods for inducing urinary voiding and defecation
CN103588861B (zh) * 2013-10-25 2015-11-04 中国药科大学 新德里金属β-内酰胺酶的抑制肽及其应用
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
RS63087B1 (sr) 2017-11-24 2022-04-29 Pharvaris Netherlands B V Novi antagonisti bradikininskog receptora b2
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505491D0 (en) * 1995-03-18 1995-05-03 Merck Sharp & Dohme Therapeutic agents
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
KR20080064908A (ko) * 2000-06-28 2008-07-09 테바 파마슈티컬 인더스트리즈 리미티드 카르베딜올
FR2822827B1 (fr) * 2001-03-28 2003-05-16 Sanofi Synthelabo Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
WO2003015698A2 (en) * 2001-08-13 2003-02-27 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
AU2003217728B2 (en) * 2002-02-08 2008-11-20 Merck Sharp & Dohme Corp. N-Biphenylmethyl aminocycloalkanecarboxamide derivatives
US20040044041A1 (en) * 2002-08-06 2004-03-04 Kuduk Scott D. 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
US20040209960A1 (en) * 2003-01-30 2004-10-21 Dynogen Pharmaceuticals, Inc. Methods of treating lower urinary tract disorders using sodium channell modulators
WO2004068928A2 (en) * 2003-02-06 2004-08-19 Uutech Limited Bradykinin b2 receptor antagonist peptide from amphibian skin
DK1492519T3 (da) * 2003-03-21 2007-03-05 Dynogen Pharmaceuticals Inc Fremgangsmåder til behandling af lidelser i den nedre urinvej ved anvendelse af alfa-2-delta-underenhedscalciumkanalsmodulatorer med glat muskel-modulatorer

Also Published As

Publication number Publication date
EP1901775A2 (de) 2008-03-26
EP1901775B1 (de) 2011-08-24
ATE521365T1 (de) 2011-09-15
AR054820A1 (es) 2007-07-18
US20080221039A1 (en) 2008-09-11
WO2007003411A2 (en) 2007-01-11
KR20080025120A (ko) 2008-03-19
CN101212985A (zh) 2008-07-02
UA96573C2 (ru) 2011-11-25
TW200800249A (en) 2008-01-01
AU2006265266A1 (en) 2007-01-11
ZA200711240B (en) 2008-08-27
EP1741444A1 (de) 2007-01-10
RU2008104134A (ru) 2009-08-10
WO2007003411A3 (en) 2007-05-18
CA2613627A1 (en) 2007-01-11
IL188316A0 (en) 2008-04-13
JP2009500362A (ja) 2009-01-08
BRPI0613724A2 (pt) 2011-02-08

Similar Documents

Publication Publication Date Title
SG163564A1 (en) Kinin antagonists for treating bladder dysfunction
WO2008008517A3 (en) Bridged diazepan orexin receptor antagonists
SI2049529T1 (sl) Substituiran diazepan oreksin receptor antagonist
WO2007126935A3 (en) Diazepan orexin receptor antagonists
MX2009005712A (es) Antagonistas de receptor de orexina de diazepam sustituido.
GEP20115140B (en) Substituted spirocyclic cgrp receptor antagonists
WO2007126934A3 (en) Amidoethylthioether orexin receptor antagonists
IL182317A0 (en) Cgrp receptor antagonists
EA201100133A1 (ru) Антагонисты рецепторов простагландина d
TN2011000171A1 (en) Isonicotinamide orexin receptor antagonists
DE602007006961D1 (de) Cgrp-rezeptorantagonisten
WO2005072308A3 (en) Cgrp receptor antagonists
MX2009005363A (es) Pirimidinas y su uso como antagonistas del receptor cxcr2.
UA100974C2 (ru) Соединения замещенных диазепанов как антагонисты орексиновых рецепторов
WO2007016087A3 (en) Heterocyclic benzodiazepine cgrp receptor antagonists
WO2007108936A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
EP1861399A4 (de) Cgrp-rezeptorantagonisten
WO2007025069A3 (en) Diazaspirodecane orexin receptor antagonists
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
WO2007136668A3 (en) N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
WO2006047196A3 (en) Cgrp receptor antagonists
SI2001456T1 (sl) Uporaba zmesi, ki vsebuje antagonist na opioidnem kapa receptorju za zdravljenje disocialnih bolezni
PL2201002T3 (pl) Antagoniści receptora 5-HT7
WO2006106358A3 (en) Use of nk-3 receptor antagonists for the treatment of nausea and vomiting